An in vitro study of the effect of size and timing of administration of titanium dioxide particles on antigen presenting activity of alveolar macrophages and peripheral blood monocytes.
Previous studies have shown that inhaled particles exacerbate asthma and allergic rhinitis. Several factors related to the particle may play a role in immune-stimulating activity; however, the underlying mechanisms remain unclear. We carried out in vitro studies to investigate the effects of TiO(2) particle exposure on antigen presenting activity and expression of the associated cell-surface molecules (Ia, B7.1, B7.2) in rat derived monocytes and alveolar macrophages, in terms of two aspects of the particles: (1) size (59 nm (ST) and 350 nm (LT) particles), and (2) the timing of particle exposure (before antigen exposure or co-administered). Results indicated that particle exposure prior to antigen exposure led to decreased antigen presenting activity in both types of cell. This decrease was greater with ST particles. In monocytes, the expression of cell surface molecules decreased similarly with both particles. Conversely, alveolar macrophages showed greater expression of Ia with ST than with LT exposures. Ia expression was confirmed to be functionally active by a mixed lymphocyte reaction. It is possible that particle exposure might result in poor antigen processing, thereby leading to decreased antigen presenting activity. Co-exposure of particles and antigen induced an increase in antigen presenting activity with both types of particle; however, ST exposure induced greater antigen presenting activity. The expression of Ia also increased similarly with both particle sizes. This suggests that, in a co-exposure situation, antigen may be processed without intensive retardation by particles, and factors other than Ia may affect antigen presenting activity. In conclusion, both size and timing of exposure to TiO(2) particles affect antigen presenting activity of monocytes and alveolar macrophages.
Munidasa
Dulee Tamirei
DT
University of Tsukuba, Tennodai, Ibaraki, Japan.
Koike
Eiko
E
Kobayashi
Takahiro
T
D000818:Animals; D000938:Antigen-Presenting Cells / Q000187:drug effects*; D000954:Antigens, Surface / Q000032:analysis; D000963:Antimetabolites; D001672:Biocompatible Materials; D001973:Bromodeoxyuridine; D005434:Flow Cytometry; D007202:Indicators and Reagents; D016676:Macrophages, Alveolar / Q000187:drug effects* / Q000276:immunology; D008297:Male; D009000:Monocytes / Q000187:drug effects* / Q000276:immunology; D010047:Ovalbumin / Q000276:immunology; D010316:Particle Size; D051381:Rats; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D014025:Titanium / Q000494:pharmacology*
D000954:Antigens, Surface; D000963:Antimetabolites; D001672:Biocompatible Materials; D007202:Indicators and Reagents; C009495:titanium dioxide; D010047:Ovalbumin; D014025:Titanium; D001973:Bromodeoxyuridine